Pricing Wars And Supply Chain Risks Will Dampen Radiotherapy Outlook
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 13 Analysts
Published
04 Aug 25
Updated
16 Aug 25
AnalystLowTarget's Fair Value
SEK 39.00
23.0% overvalued intrinsic discount16 Aug
SEK 47.96
1Y
-30.0%7D
1.0%